Searched for
WOCKHARDT MD
Behind India's Rs 5.5 lakh crore FII selloff lies a hidden list of 84 multibagger winnersForeign institutional investors have sold Indian stocks worth Rs 5.5 lakh crore. However, a hidden list reveals 84 stocks where FIIs have a...- Wockhardt snags Covid-19 vaccine manufacturing deal from the UK govtThis deal by Wockhardt entails only manufacturing the vaccine only for the United Kingdom. The government has reserved one fill and finish ...
- Wockhardt MD Murtaza Khorakiwala is back in the racquet club after a skiing holidayA tennis player as a youngster, Khorakiwala has taken up the sport again to give priority to his fitness.
- Kotak Mahindra rolls out mobile medical vans under CSRAs part of the agreement, three medical vans which act as primary healthcare centres on wheels would be managed by the Wockhardt Foundation...
- Wockhardt sets up its first manufacturing facility in Middle East"With the new facility in the Middle East, we aim to focus on our commitment to developing NCEs to fight the health issues," Wockhardt Foun...
- Sell Wockhardt with a stop loss of Rs 1830: Sandeep WagleWockhardt Ltd is a ‘sell’ call with a target of Rs 1620 and a stop loss of Rs 1830.
- Sell Wockhardt with a target of 1012: Sandeep WagleWockhardt Ltd is a ‘BUY’ call with a target of Rs 1012 and a stop loss of Rs 934.
- Wockhardt moved up so much due to restructring: Deven ChokseyIt was quite significantly battered down in earlier period and as a result of the efforts of restructuring, the stock has bounced back that...
- Buy Wockhardt on long term: Sandeep Wagle"380 to 370, I am recommending a buy on Wockhardt, stop loss of 355, target of 435 this is a little longer term call talk of the next two t...
- Wockhardt Pharma Q1 net at Rs 194 croreMumbai-based Wockhardt Pharma bounced back into the black with a net profit of Rs 193.96 crore in the first quarter ended June.
- Buy Wockhardt on declines for: Sandeep Wagle"It is a buy on decline, around 440-430 is an ideal level to buy that stock as of now for me."
- Buy Wockhardt for target of Rs 405: AptartThe analyst is of the view that the company has seen a price and volume breakout in monthly charts.
- Positive on Wockhardt and Titan: Sandeep WagleWe have booked profits at 190 or possibly around 200-205 and move from 205 to 260 has just happened in 3 days.
- Buy Wockhardt at current levels: Sandeep WagleSandeep Wagle, Founder & MD, APTART Technical Advisory Services, aptartindia.com in an interview with ET Now talks about Wockhardt.
- Would avoid Wockhardt: Sandeep Wagle, APTART Technical Advisory ServicesSandeep Wagle, Founder & MD, APTART Technical Advisory Services, in a chat with ET Now talks about Wockhardt, Rajshree and Venus Remedies.
- Buy Wockhardt for target of 140-145: Sandeep WagleSandeep Wagle, Founder & MD, APTART Technical Advisory Services, www.aptartindia.com spoke to ET Now on Healthcare stocks.
- Wockhardt-Kamineni pact headed for breakupThe tie-up between Mumbai-based healthcare services major Wockhardt and city-based hospital Kamineni to run two hospitals here seems to be ...
- Wockhardt stalls PE fund-raising plansDifferences over valuation have held up Wockhardt Hospital’s plan to raise money from private equity (PE) investors.
- Wockhardt Hospitals to raise funds through PEWockhardt Hospitals on Sunday said it is looking at raising funds through private equity.
- Wockhardt Hospitals plans to foray into organ transplantWockhardt Hospitals is planning to make a major foray into the organ transplantation segment.
Load More
